S

STERIS plc (STE)

NYQ – Real vaqt narxi. Valyuta: USD

210.85

+9.00 (4.46%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

S

STERIS plc (STE)

NYQ – Real vaqt narxi. Valyuta: USD

210.85

+9.00 (4.46%)

Yopilishda: May 12, 2026, 4:00 PM EDT

12.05.2026

STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading

STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.

12.05.2026

STERIS plc (STE) Q4 2026 Earnings Call Transcript

11.05.2026

Steris (STE) Q4 Earnings and Revenues Miss Estimates

Steris (STE) came out with quarterly earnings of $2.83 per share, missing the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.74 per share a year ago.

11.05.2026

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

Medical equipment maker Steris forecast fiscal 2027 profit above Wall Street expectations on Monday, betting on strong demand ‌for its sterilization services despite narrowly missing estimates for fourth-quarter adjusted profit.

11.05.2026

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.

07.05.2026

STERIS Appoints Pierre Boulud to Board of Directors

DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are pleased to welcome Pierre to our Board,” said Mohsen Sohi, Chairman of STERIS.

05.05.2026

STERIS Announces Dividend of $0.63 per share

DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on June 26, 2026, to shareholders of record at the close of business on June 8, 2026.

Videolar

No Data

There is no data to display

Press-relizlar

11.05.2026

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.

07.05.2026

STERIS Appoints Pierre Boulud to Board of Directors

DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are pleased to welcome Pierre to our Board,” said Mohsen Sohi, Chairman of STERIS.

05.05.2026

STERIS Announces Dividend of $0.63 per share

DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on June 26, 2026, to shareholders of record at the close of business on June 8, 2026.

04.02.2026

STERIS Announces Financial Results for Fiscal 2026 Third Quarter

Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.96; adjusted EPS increased to $2.53 Fiscal 2026 outlook maintained DUBLIN, IRELAND, Feb. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 third quarter ended December 31, 2025. Total revenue from continuing operations for the third quarter of fiscal 2026 increased 9% to $1.5 billion compared with $1.4 billion in the third quarter of fiscal 2025.

Search stocks

STERIS plc (STE)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

STERIS plc (STE)

STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading

STERIS plc (STE) Q4 2026 Earnings Call Transcript

Steris (STE) Q4 Earnings and Revenues Miss Estimates

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

STERIS Appoints Pierre Boulud to Board of Directors

STERIS Announces Dividend of $0.63 per share

Videolar

No Data

Press-relizlar

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

STERIS Appoints Pierre Boulud to Board of Directors

STERIS Announces Dividend of $0.63 per share

STERIS Announces Financial Results for Fiscal 2026 Third Quarter